Effects of scrocaffeside A from Picrorhiza Scrophulariiflora on immunocyte function in vitro

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 3, 2009, Pages 451-458

  An, Na ^a   Wang, Dacheng ^a   Zhu, Tongfei ^b   Zeng, Sheng ^a   Cao, Yongguo ^a   Cui, Jian ^a   Deng, Xuming ^a   Song, Yu ^a  

^a JILIN UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cytokines; Immunoenhancement; In vitro; Picrorhiza scrophulariiflora; Scrocaffeside

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PICRORHIZA SCROPHULARIIFLORA EXTRACT; PLANT EXTRACT; PLANT GLYCOSIDE; SCROCAFFESIDE A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG STRUCTURE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERITONEUM MACROPHAGE; PICRORHIZA KURROA; PICRORHIZA SCROPHULARIIFLORA; PLANT ROOT; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

MAMMALIA; PICRORHIZA SCROPHULARIIFLORA;

EID: 70350690549     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970902783092     Document Type: Article

References (30)

1. Kirtikar, K. R., Basu, B.D. Indian medicinal plants, vol.III. Allahabad, Lalit Mohan Basu, 1935. pp. 1825,1826.
2. Dey, A.C., Bhishen, S., Mahendra, P.S. Indian medicinal plants used in ayurvedic preparations. J. Res. Indian Med. 1980, 81.
3. Chaturvedi, G.N., Singh, R.H. Jaundice of infectious hepatitis and its treatment with an indigenous drug, Picrorhiza kurroa. J. Res. Indian Med. 1966, 1, 1-13.
4. Handa, S.S., Sharma, A., Chakraborti, K.K. Natural products and plants as liver protecting drugs. Fitoterapia. 1986, 57, 307-349.
5. Dorsch, W., Stuppner, H., Wagner, H., Gropp, M., Demoulin, S., Ring, J. Antiasthmatic effects of Picrorhiza kurroa, Androsin prevents allergen and PAV-induced bronchial obstruction in guinea pigs. Int. Arch. Allergy. Appl. Immunol. 1991, 95(2-3), 128-133.
6. Rajaram D. A preliminary clinical trial of Picrorhiza kurroa in bronchial asthma. Bombay Hosp. J. 1976, 18, 66-69.
7. Mittal, G. C., Saxena, S., Kanchan, S. K., Mangal, O.P., Dandiya, P. C. Clinical trials of bibarin in liver disorders with special to infective hepatitis. Indian Pract. 8 1978, 683-693.
8. Joy, K.L., Kuttan, R. Anti-diabetic activity of Picrorrhiza kurroa extract. J. Ethnopharmacol. 1999, 67(2), 143-148.
9. Joy, K.L., Rajeshkumar, N.V., Kuttan, G., Kuttan, R. Effect of Picrorrhiza kurra extract on transplanted tumours and chemical carcinogenesis in mice. J. Ethnopharmacol. 2000, 71(1-2), 261-266.
10. Gupta, A., Khajuria, A., Singh, J., Bedi, K.l., Satti, N.K., Dutt, P., Suri, K.A., Suri, O.P., Qazi, G.N. Immunomodulatory activity of biopolymeric fraction RLJ-NE-205 from Picrorhiza kurroa. Int. Immunopharmacol. 2006, 6(10), 1543-1549.
11. Khajuria, A., Gupta, A., Singh, S., Malik, F., Singh, J., Suri, K.A., Satti, N.K., Qazi, G.N., Srinivas, V.K., Gopinathan ; Ella, K. RLJNE- 299A: A new plant based vaccine adjuvant. Vaccine. 2007, 25(14), 2706-2715.
12. Murphy, K.M., Reiner, S.L. The lineage decision of helper T cells. Nat. Rev. Immunol. 2002, 2(12), 933-944.
13. Zhu, T.F., Huang, K.Y., Deng, X.M., Zhang, Y., Xiang, H., Gao, H.Y., Wang, D.C. Three new caffeoyl glycosides from the roots of Picrorhiza scrophulariiflora. Molecules. 2008, 13(4), 729-735.
14. Joy, K.L., Kuttan, R. Antioxidant activity of selected plant extracts. Amala Res. Bull. 1995, 15, 68-71.
15. Labadie, R.P., Vander, N., Simsons, J.M., Desilva, K.T.D. An ethanopharmacognostic approach to the search for immunomodulators of plant origin. Planta Med. 1989, 55, 339-348.
16. Rastogi, R., Saksena, S., Garg, N.K., Dhawan, B.N. Effect of Picroliv on anti-oxidant system in liver of rats after partial hepatoctomy. Phytother. Res. 1995, 9, 364-367.
17. Simsons, J.M., Hart, B.A., Ladadie, R.P. Metabolic activation of natural phenols in to selective oxidactive burst agonists by activated human neutrophils. Free. Radical Bio. Med. 1990, 8, 251-258.
18. Jia, Q., Hong, M.F., Minter, D. Pikuroside: A novel iridoid from Picrorhiza kurroa. J. Nat. Prod. 1999, 62(6), 901-903.
19. Benjamini, E; Coico, R; Sunshine, G. 2000. Immunology: A Short Course (4th ed.). New York, Wiley, p. 201.
20. Eberlein, T.J., Rosenstein, M., Rosenberg, S.A. Regression of a disseminated sungeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. J. Exp. Med. 1982, 156(2), 385-397.
21. Schmidt-wolf, I.G., Negrin, R.S., Kiem, H.P., Blume, K.G., Weissman, I.L. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent anti-tumor cell activity. J. Exp. Med. 1991, 174(1), 139-149.
22. Mariani, E., Meneghetti, A., Tarozzi, A., Cattini, L., Facchini, A. Interleukin-12 induces effi cient lysis of natural killer-sensitive and natural killer-resistant human osteosarcoma cells; the synergistic effect interleukin-2. Scand. J. Immunol. 2000, 51(6), 618-625.
23. Zoll, B., Lefterova, P., Ebert, O., Huhn, D., Von Ruecker, A., Schmidt Wolf, I.G. Modulation of cell surface markers on NK-like T lymphocytes by using IL-2, IL-7 or IL-12 in vitro stimulation. Cytokine. 2000, 12(3), 1385-1390.
24. Carlens, S., Gilljam, M., Chambers, B.J., Aschan, J., Guven, H., Ljunggren, H.G., Christensson, B., Dilber, M.S. A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells. Hum. Immunol. 2001, 62(10), 1092-1098.
25. Zhang, Q.H., Lin, Z.B. The antitumor activity of Ganoderma lucidum polysaccharides is related to tumor necrosis-α and interferon-γ. Int. J. Med. Mushrooms. 1999, 1(1), 207-215.
26. Cao, L.Z., Lin, Z.B. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol. Lett. 2002, 83(3), 163-169.
27. Lucey, D.R., Clerici, M., Shearer, G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 1996, 9(4), 532-562.
28. Van der Meide, P.H., Schellekens, H. Cytokines and the immune response. Biother. 1996, 8(3-4), 243-249.
29. Kim, S.H., Evans, C.H., Kim, S., Oligino, T., Ghivizzani, S.C; Robbins, P.D. Gene therapy for established murine collageninduced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4. Arthritis. Res. Ther. 2000, 2(4), 293-302.
30. Asadullah, K., Sterry, W., Volk, H.D. Interleukin 10 therapy- review of a new approach. Pharmacol. Rev. 2003, 55(2), 241-269.